1. Home
  2. NET vs RMD Comparison

NET vs RMD Comparison

Compare NET & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cloudflare Inc.

NET

Cloudflare Inc.

N/A

Current Price

$191.50

Market Cap

75.4B

Sector

Technology

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

N/A

Current Price

$246.52

Market Cap

36.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NET
RMD
Founded
2009
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.4B
36.4B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
NET
RMD
Price
$191.50
$246.52
Analyst Decision
Buy
Buy
Analyst Count
28
13
Target Price
$225.89
$290.00
AVG Volume (30 Days)
2.7M
909.8K
Earning Date
02-05-2026
01-29-2026
Dividend Yield
N/A
0.97%
EPS Growth
N/A
29.59
EPS
N/A
9.77
Revenue
$2,013,376,000.00
$5,257,400,000.00
Revenue This Year
$29.73
$9.85
Revenue Next Year
$27.56
$7.32
P/E Ratio
N/A
$25.31
Revenue Growth
28.07
9.36
52 Week Low
$89.42
$199.92
52 Week High
$260.00
$293.81

Technical Indicators

Market Signals
Indicator
NET
RMD
Relative Strength Index (RSI) 38.56 42.00
Support Level $199.52 $243.62
Resistance Level $215.30 $255.83
Average True Range (ATR) 6.39 5.69
MACD -0.16 0.01
Stochastic Oscillator 1.04 37.85

Price Performance

Historical Comparison
NET
RMD

About NET Cloudflare Inc.

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: